Prospective Randomized Trial of the Effective Therapy for Small, Solitary HCC Comparing Operation and Percutaneous Ethanol Injection Therapy
To compare the below things between operation group and percutaneous ethanol injection
therapy (PEIT) group:
1. Survival
- 5 year overall survival rate
- Disease free survival rate
2. Recurrence
- Cumulative recurrence rate
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
overall survival rate
5 year
Yes
J H Yoon, Professor
Principal Investigator
Seoul National University Hospital
Korea: Food and Drug Administration
07-2007-006
NCT00357422
October 2005
April 2013
Name | Location |
---|